Stoke Therapeutics Inc (STOK) financials · rev $184.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Stoke Therapeutics Inc (STOK) rev $184.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $184.4M | $36.6M |
| Operating Income | -$20.6M | -$101.4M |
| Net Income | -$6.88M | -$89.0M |
| EPS (Diluted) | -$0.12 | -$1.65 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $418.4M | $271.6M |
| Current Assets | $305.7M | $232.8M |
| Cash & Equivalents | $84.2M | $128.0M |
| PP&E | $3.15M | $3.91M |
| Total Liabilities | $66.0M | $42.5M |
| Current Liabilities | $57.9M | $40.1M |
| Shareholders' Equity | $352.5M | $229.0M |
| Retained Earnings | -$497.7M | -$490.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $45.6M | -$86.9M |
| CapEx | $670.0K | $203.0K |
| Investing Cash Flow | -$186.8M | -$107.5M |
| Financing Cash Flow | $97.4M | $131.1M |
| Net Change in Cash | -$43.8M | -$63.2M |
| Free Cash Flow | $44.9M | -$87.1M |
FAQ
What is STOK P/E and revenue?
Stoke Therapeutics Inc (STOK) rev $184.4M.
What is STOK revenue?
Stoke Therapeutics Inc last cached revenue is $184.4M (FY2025).
Is STOK profitable?
Stoke Therapeutics Inc last cached net income is -$6.88M (FY2025).
What are STOK total assets?
Stoke Therapeutics Inc last cached total assets are $418.4M (FY2025).
What is STOK free cash flow?
Stoke Therapeutics Inc last cached free cash flow is $44.9M (FY2025).
Not investment advice. Cached statements, not a live tape.